載入...
The prognostic value of PD‐L1 expression in upper tract urothelial carcinoma varies according to platelet count
Programmed cell death ligand‐1 (PD‐L1) is a ligand for programmed cell death‐1 (PD‐1) that negatively regulates T‐cell activation and plays a crucial role in suppressing anti‐tumor host immunity. Although PD‐L1 is a promising immunotherapy target in various cancers, including urothelial carcinoma (U...
Na minha lista:
| 發表在: | Cancer Med |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6143937/ https://ncbi.nlm.nih.gov/pubmed/30062756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1686 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|